Mifepristone Returns to the Shadow Docket
Drug makers seek interim relief after the U.S. Court of Appeals for the Fifth Circuit blocks FDA rule allowing mifepristone prescriptions via telemedicine.
Original Source
Read the full article at Reason →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.